))
Episode 40. Management of Newly Diagnosed AL Amyloidosis with Dr. Angela Dispenzieri
Manage episode 402140665 series 3369804
Inhoud geleverd door Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
In this episode we discuss the management of newly diagnosed AL amyloidosis with Dr. Angela Dispenzieri from the Mayo Clinic.
Here are the key articles discussed:
1. Optimal use of tissue biopsy in AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/28271734/
2. Mayo 2004 staging: https://pubmed.ncbi.nlm.nih.gov/15365071/
3. Mayo 2012 staging: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675680/
4. Renal staging: https://pubmed.ncbi.nlm.nih.gov/25115890/
5. Hematologic and cardiac response criteria in AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/23091105/
6. ANDROMEDA Trial: Dara-VCD vs VCD in newly diagnosed AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/34192431/
7. How I Treat AL Amyloidosis: https://pubmed.ncbi.nlm.nih.gov/34517412/
8. Venetoclax in AL amyloidosis (largest retrospective study till date):
45 afleveringen
Delen
